Tenderwize
Zurück zur Suche

Open-House Rabatt Contracts for Follitropin beta

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 30, 2027 · 249 days left·Open·Supplies
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-04 - Follitropin beta

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

52 / 100

Komplexität

58 / 100

Risikofaktoren

Electronic submission through the portal is not allowed, despite portal-based communication; submission must follow the...

Although entry is possible at any time during the contract period, the notice states that timely submission by the 3rd...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclude pharmaceutical rebate contracts for the active substance Follitropin beta.
  • Provide supplies under an Open-House procedure with standard, non-negotiated terms.
Vollständige Zusammenfassung anzeigen

This is a German Open-House supply arrangement for pharmaceutical products, specifically Rabattverträge for the active substance Follitropin beta. The contracting buyers are Techniker Krankenkasse as lead buyer, with HEK and hkk as participating buyers. It is not an exclusive contract: all suitable pharmaceutical companies may join during the contract period under uniform terms, with no individual negotiations. The contract runs for up to 24 months from 01.05.2025 and ends no later than 30.04.2027. Electronic submission via the portal is not allowed; contracts must be submitted by email with qualified electronic signature or by post, with details in the participation and contract documents.

Risiken

Electronic submission through the portal is not allowed, despite portal-based communication; submission must follow the...

Although entry is possible at any time during the contract period, the notice states that timely submission by the 3rd...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Bidder must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG for the offered medicinal products.
  • Bidder must have its seat in Germany, another EU Member State, or another EEA state.
  • Bidder must have a valid marketing authorisation for the relevant medicinal product(s), or otherwise be legally entitled to place them on the market in its own name.

Zuschlagskriterien

Lot 1

Other criterion: participation and suitability requirements; no numeric weight stated.

Auftraggeber

Ort

Hamburg, DEU

Kennung

992-80116-93

Tätigkeit

Health

Lose (1)

LOT-0001

Open-House Rabatt Contracts for Follitropin beta

Open-House supply arrangement for pharmaceutical rebate contracts under Section 130a(8) SGB V for the active ingredient Follitropin beta. Scope is nationwide in Germany. The lot information comes from the structured notice and XML notice.

SuppliesEU fundedElectronic submission

Ort

DE600, Germany

Dauer

Apr 2025 - Apr 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

Other criterion: participation and suitability requirements; no numeric weight stated.

Frist

Deadline Apr 30, 2027

Vergabedetails

Veröffentlichungsdatum
16 Mar 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
171456-2025

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3